Does ATORVASTATIN Cause Hepatic steatosis? 301 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 301 reports of Hepatic steatosis have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.4% of all adverse event reports for ATORVASTATIN.
301
Reports of Hepatic steatosis with ATORVASTATIN
0.4%
of all ATORVASTATIN reports
7
Deaths
88
Hospitalizations
How Dangerous Is Hepatic steatosis From ATORVASTATIN?
Of the 301 reports, 7 (2.3%) resulted in death, 88 (29.2%) required hospitalization, and 9 (3.0%) were considered life-threatening.
Is Hepatic steatosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 301 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Hepatic steatosis?
METHOTREXATE (1,400)
ADALIMUMAB (1,058)
ETANERCEPT (620)
TOCILIZUMAB (476)
TOFACITINIB (405)
LEFLUNOMIDE (359)
HYDROXYCHLOROQUINE (358)
ABATACEPT (345)
METFORMIN (343)
INFLIXIMAB (325)
Which ATORVASTATIN Alternatives Have Lower Hepatic steatosis Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM